[HTML][HTML] CRISPR screens identify gene targets at breast cancer risk loci
Background Genome-wide association studies (GWAS) have identified> 200 loci associated
with breast cancer risk. The majority of candidate causal variants are in non-coding regions …
with breast cancer risk. The majority of candidate causal variants are in non-coding regions …
[HTML][HTML] CRISPR screens identify gene targets at breast cancer risk loci
NK Tuano, J Beesley, M Manning, W Shi… - Genome …, 2023 - ncbi.nlm.nih.gov
Background Genome-wide association studies (GWAS) have identified> 200 loci associated
with breast cancer risk. The majority of candidate causal variants are in non-coding regions …
with breast cancer risk. The majority of candidate causal variants are in non-coding regions …
[HTML][HTML] CRISPR screens identify gene targets at breast cancer risk loci
NK Tuano, J Beesley, M Manning… - Genome …, 2023 - genomebiology.biomedcentral.com
Genome-wide association studies (GWAS) have identified> 200 loci associated with breast
cancer risk. The majority of candidate causal variants are in non-coding regions and likely …
cancer risk. The majority of candidate causal variants are in non-coding regions and likely …
CRISPR screens identify gene targets at breast cancer risk loci
NK Tuano, J Beesley, M Manning, W Shi… - Genome …, 2023 - research.monash.edu
Background: Genome-wide association studies (GWAS) have identified> 200 loci
associated with breast cancer risk. The majority of candidate causal variants are in non …
associated with breast cancer risk. The majority of candidate causal variants are in non …
CRISPR screens identify gene targets at breast cancer risk loci
NK Tuano, J Beesley, M Manning, W Shi… - 2023 - digital.library.adelaide.edu.au
Background: Genome-wide association studies (GWAS) have identified> 200 loci
associated with breast cancer risk. The majority of candidate causal variants are in …
associated with breast cancer risk. The majority of candidate causal variants are in …
CRISPR screens identify gene targets at breast cancer risk loci
NK Tuano, J Beesley, M Manning, W Shi… - Genome …, 2023 - experts.nebraska.edu
Background: Genome-wide association studies (GWAS) have identified> 200 loci
associated with breast cancer risk. The majority of candidate causal variants are in non …
associated with breast cancer risk. The majority of candidate causal variants are in non …
CRISPR screens identify gene targets at breast cancer risk loci
NK Tuano, J Beesley, M Manning, W Shi… - Genome …, 2023 - search.proquest.com
Background Genome-wide association studies (GWAS) have identified> 200 loci associated
with breast cancer risk. The majority of candidate causal variants are in non-coding regions …
with breast cancer risk. The majority of candidate causal variants are in non-coding regions …
[引用][C] CRISPR screens identify gene targets at breast cancer risk loci
NK Tuano, J Beesley, M Manning, W Shi… - 2023 - europepmc.org
Background: Genome‑wide association studies (GWAS) have identified> 200 loci
associated with breast cancer risk. The majority of candidate causal variants are in non …
associated with breast cancer risk. The majority of candidate causal variants are in non …
CRISPR screens identify gene targets at breast cancer risk loci
NK Tuano, J Beesley, M Manning, W Shi… - 2023 - hekyll.services.adelaide.edu.au
Background: Genome-wide association studies (GWAS) have identified> 200 loci
associated with breast cancer risk. The majority of candidate causal variants are in …
associated with breast cancer risk. The majority of candidate causal variants are in …
CRISPR screens identify gene targets at breast cancer risk loci
NK Tuano, J Beesley, M Manning, W Shi… - Genome …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Genome-wide association studies (GWAS) have identified> 200 loci associated
with breast cancer risk. The majority of candidate causal variants are in non-coding regions …
with breast cancer risk. The majority of candidate causal variants are in non-coding regions …